ET-1-induced growth promoting responses involving ERK1/2 and PKB signaling and Egr-1 expression are mediated by Ca2+/CaM-dependent protein kinase-II in vascular smooth muscle cells

Cell Calcium

Volumn 54, Issue 6, 2013, Pages 428-435

  Bouallegue, Ali ^a,b   Simo Cheyou, Estelle R ^a,c   Anand Srivastava, Madhu B ^b   Srivastava, Ashok K ^a,b,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

CaMKII; Egr 1; Endothelin; ERK1 2; PKB; VSMC

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CALMIDAZOLIUM; CALMODULIN; ENDOTHELIN 1; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PEPTIDE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR EGR 1;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

CAMKII; EGR-1; ENDOTHELIN; ERK1/2; PKB; VSMC;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELLS, CULTURED; EARLY GROWTH RESPONSE PROTEIN 1; ENDOTHELIN-1; FOCAL ADHESION KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84888872999     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2013.10.002     Document Type: Article

References (52)

1. Webb D.J. Endothelin: from molecule to man. Br. J. Clin. Pharmacol. 1997, 44:9-20.
2. Battistini B., Chailler P., D'Orleans-Juste P., Briere N., Sirois P. Growth regulatory properties of endothelins. Peptides 1993, 14:385-399.
3. Iwasaki H., Eguchi S., Ueno H., Marumo F., Hirata Y. Endothelin-mediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor. Endocrinology 1999, 140:4659-4668.
4. 2+ influx and endothelin-1-induced intracellular mitogenic cascades in rabbit internal carotid artery vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 2002, 40:307-314.
5. Mathew V., Hasdai D., Lerman A. The role of endothelin in coronary atherosclerosis. Mayo Clin. Proc. 1996, 71:769-777.
6. Haynes W.G., Webb D.J. Endothelin as a regulator of cardiovascular function in health and disease. J. Hypertens. 1998, 16:1081-1098.
7. Burke S.E., Lubbers N.L., Gagne G.D., et al. Selective antagonism of the ET(A) receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigs. J. Cardiovasc. Pharmacol. 1997, 30:33-41.
8. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990, 348:730-732.
9. Sakurai T., Yanagisawa M., Takuwa Y., et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990, 348:732-735.
10. Gellai M., Fletcher T., Pullen M., Nambi P. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am. J. Physiol. 1996, 271:R254-R261.
11. Alonso D., Radomski M.W. The nitric oxide-endothelin-1 connection. Heart Fail. Rev. 2003, 8:107-115.
12. D'Orleans-Juste P., Labonte J., Bkaily G., Choufani S., Plante M., Honore J.C. Function of the endothelin(B) receptor in cardiovascular physiology and pathophysiology. Pharmacol. Ther. 2002, 95:221-238.
13. Pollock D.M., Keith T.L., Highsmith R.F. Endothelin receptors calcium signaling. FASEB J. 1995, 9:1196-1204.
14. Bogoyevitch M.A., Glennon P.E., Anderson M.B., et al. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J. Biol. Chem. 1994, 269:1110-1119.
15. Yamboliev I.A., Hruby A., Gerthoffer W.T. Endothelin-1 activates MAP kinases and c-Jun in pulmonary artery smooth muscle. Pulm. Pharmacol. Ther. 1998, 11:205-208.
16. Yoshizumi M., Kim S., Kagami S., et al. Effect of endothelin-1 (1-31) on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells. Br. J. Pharmacol. 1998, 125:1019-1027.
17. Sorokin A., Kozlowski P., Graves L., Philip A. Protein-tyrosine kinase Pyk2 mediates endothelin-induced p38 MAPK activation in glomerular mesangial cells. J. Biol. Chem. 2001, 276:21521-21528.
18. Bouallegue A., Daou G.B., Srivastava A.K. Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr. Vasc. Pharmacol. 2007, 5:45-52.
19. Foschi M., Chari S., Dunn M.J., Sorokin A. Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase. EMBO J. 1997, 16:6439-6451.
20. Flamant M., Tharaux P.L., Placier S., et al. Epidermal growth factor receptor trans-activation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice. FASEB J. 2003, 17:327-329.
21. Yamauchi J., Miyamoto Y., Kokubu H., et al. Endothelin suppresses cell migration via the JNK signaling pathway in a manner dependent upon Src kinase, Rac1, and Cdc42. FEBS Lett. 2002, 527:284-288.
22. Kodama H., Fukuda K., Takahashi T., et al. Role of EGF Receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes. J. Mol. Cell. Cardiol. 2002, 34:139-150.
23. Kodama H., Fukuda K., Takahashi T., et al. Selective involvement of p130Cas/Crk/Pyk2/c-Src in endothelin-1-induced JNK activation. Hypertension 2003, 41:1372-1379.
24. Lowe H.C., Fahmy R.G., Kavurma M.M., Baker A., Chesterman C.N., Khachigian L.M. Catalytic oligodeoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis. Circ. Res. 2001, 89:670-677.
25. Khachigian L.M. Early growth response-1 in cardiovascular pathobiology. Circ. Res. 2006, 98:186-191.
26. Aggeli I.K., Beis I., Gaitanaki C. ERKs and JNKs mediate hydrogen peroxide-induced Egr-1 expression and nuclear accumulation in H9c2 cells. Physiol. Res. 2010, 59:443-454.
27. 2+, calmodulin, and protein kinase C in H2O2-induced activation of ERK1/2, p38 MAPK, and protein kinase B signaling in vascular smooth muscle cells. Antioxid. Redox. Signal. 2004, 6:353-366.
28. Rajagopalan S., Kurz S., Munzel T., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 1996, 97:1916-1923.
29. Soderling T.R. Structure and regulation of calcium/calmodulin-dependent protein kinases II and IV. Biochim. Biophys. Acta 1996, 1297:131-138.
30. Cruzalegui F.H., Kapiloff M.S., Morfin J.P., Kemp B.E., Rosenfeld M.G., Means A.R. Regulation of intrasteric inhibition of the multifunctional calcium/calmodulin-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:12127-12131.
31. 2+/calmodulin-dependent protein kinase II, Differential expression in rat brain and aorta. J. Biol. Chem. 1993, 268:14443-14449.
32. Bouallegue A., Daou G.B., Srivastava A.K. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2072-H2079.
33. Nguyen A., Chen P., Cai H. Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells. FEBS Lett. 2004, 572:307-313.
34. Pandey S.K., Théberge J.-F., Bernier M., Srivastava A.K. Phosphatidylinositol 3-kinase requirement in activation of the ras/C-raf-1/MEK/ERK and p70(s6k) signaling cascade by the insulinomimetic agent vanadyl sulfate. Biochemistry 1999, 38:14667-14675.
35. Rocic P., Govindarajan G., Sabri A., Lucchesi P.A. A role for PYK2 in regulation of ERK1/2 MAP kinases and PI 3-kinase by ANG II in vascular smooth muscle. Am. J. Physiol. Cell Physiol. 2001, 280:C90-C99.
36. Muthalif M.M., Benter I.F., Uddin M.R., Malik K.U. Calcium/calmodulin-dependent protein kinase IIalpha mediates activation of mitogen-activated protein kinase and cytosolic phospholipase A2 in norepinephrine-induced arachidonic acid release in rabbit aortic smooth muscle cells. J. Biol. Chem. 1996, 271:30149-30157.
37. Fatima S., Yaghini F.A., Ahmed A., Khandekar Z., Malik K.U. CaM kinase IIalpha mediates norepinephrine-induced translocation of cytosolic phospholipase A2 to the nuclear envelope. J. Cell. Sci. 2003, 116:353-365.
38. Muthalif M.M., Benter I.F., Uddin M.R., Harper J.L., Malik K.U. Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J. Pharmacol. Exp. Ther. 1998, 284:388-398.
39. 2+/calmodulin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic vascular smooth muscle cells. Circ. Res. 1997, 81:575-584.
40. Ginnan R., Pfleiderer P.J., Pumiglia K., Singer H.A. PKC-delta and CaMKII-delta 2 mediate ATP-dependent activation of ERK1/2 in vascular smooth muscle. Am. J. Physiol. Cell Physiol. 2004, 286:C1281-C1289.
41. Daou G.B., Srivastava A.K. Reactive oxygen species mediate Endothelin-1-induced activation of ERK1/2. PKB, and Pyk2 signaling, as well as protein synthesis, in vascular smooth muscle cells. Free Radic. Biol. Med. 2004, 37:208-215.
42. Cipolletta E., Monaco S., Maione A.S., et al. Calmodulin-dependent kinase II mediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase. Endocrinology 2010, 151:2747-2759.
43. Monaco S., Illario M., Rusciano M.R., et al. Insulin stimulates fibroblast proliferation through calcium-calmodulin-dependent kinase II. Cell Cycle 2009, 8:2024-2030.
44. Illario M., Monaco S., Cavallo A.L., et al. Calcium-calmodulin-dependent kinase II (CaMKII) mediates insulin-stimulated proliferation and glucose uptake. Cell. Signal. 2009, 21:786-792.
45. 2+/calmodulin-dependent protein kinase II in development of vascular dysfunction in diabetic rats with hypertension. Cell Biochem. Funct. 2008, 26:256-263.
46. 2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. J. Biol. Chem. 2000, 275:15239-15245.
47. 2+/calmodulin-dependent kinase II delta (CaMKIIdelta) controls neointima formation after carotid ligation and vascular smooth muscle cell proliferation through cell cycle regulation by p21. J. Biol. Chem. 2011, 286:7990-7999.
48. 2+/calmodulin-dependent protein kinase II. RAS-GTPase and 20-hydroxyeicosatetraenoic acid attenuates the development of diabetes-induced vascular dysfunction in the rat carotid artery. Pharmacol. Res. 2005, 52:252-257.
49. Muthalif M.M., Karzoun N.A., Benter I.F., et al. Functional significance of activation of calcium/calmodulin-dependent protein kinase II in angiotensin II-induced vascular hyperplasia and hypertension. Hypertension 2002, 39:704-709.
50. Sachinidis A., Weisser P., Ko Y., Angiotensin I.I., et al. induces formation of the early growth response gene-1 protein in rat vascular smooth muscle cells. FEBS Lett. 1992, 313:109-112.
51. 2+-dependent Egr-1 expression and subsequently inhibits vascular smooth muscle cell proliferation induced by angiotensin II. Cell. Physiol. Biochem. 2009, 23:295-304.
52. Pagel J.I., Deindl E. Disease progression mediated by egr-1 associated signaling in response to oxidative stress. Int. J. Mol. Sci. 2012, 13:13104-13117.